vs
Side-by-side financial comparison of CALERES INC (CAL) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
CALERES INC is the larger business by last-quarter revenue ($790.1M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 0.3%, a 6.5% gap on every dollar of revenue. On growth, CALERES INC posted the faster year-over-year revenue change (6.6% vs -1.7%). Over the past eight quarters, CALERES INC's revenue compounded faster (6.5% CAGR vs -0.1%).
Caleres Inc. is an American footwear company that owns and operates a variety of footwear brands. Its headquarters is located in Clayton, Missouri, a suburb of St. Louis. The company was founded in 1878 as Bryan, Brown & Company in St. Louis, though it underwent several name changes. The Hamilton-Brown Shoe Company was the largest manufacturer of shoes in America in the early 20th century, but it went bankrupt in June 1939.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
CAL vs MD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $790.1M | $493.8M |
| Net Profit | $2.4M | $33.7M |
| Gross Margin | 41.8% | — |
| Operating Margin | 1.5% | 9.9% |
| Net Margin | 0.3% | 6.8% |
| Revenue YoY | 6.6% | -1.7% |
| Net Profit YoY | -94.2% | 10.5% |
| EPS (diluted) | $0.07 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $790.1M | $493.8M | ||
| Q3 25 | $658.5M | $492.9M | ||
| Q2 25 | $614.2M | $468.8M | ||
| Q1 25 | $639.2M | $458.4M | ||
| Q4 24 | $740.9M | $502.4M | ||
| Q3 24 | $683.3M | $511.2M | ||
| Q2 24 | $659.2M | $504.3M | ||
| Q1 24 | $697.1M | $495.1M |
| Q4 25 | $2.4M | $33.7M | ||
| Q3 25 | $6.7M | $71.7M | ||
| Q2 25 | $6.9M | $39.3M | ||
| Q1 25 | $4.9M | $20.7M | ||
| Q4 24 | $41.4M | $30.5M | ||
| Q3 24 | $30.0M | $19.4M | ||
| Q2 24 | $30.9M | $-153.0M | ||
| Q1 24 | $55.7M | $4.0M |
| Q4 25 | 41.8% | — | ||
| Q3 25 | 43.4% | — | ||
| Q2 25 | 45.4% | — | ||
| Q1 25 | 43.0% | — | ||
| Q4 24 | 44.1% | — | ||
| Q3 24 | 45.5% | — | ||
| Q2 24 | 46.9% | — | ||
| Q1 24 | 43.9% | — |
| Q4 25 | 1.5% | 9.9% | ||
| Q3 25 | 1.4% | 13.8% | ||
| Q2 25 | 1.9% | 12.8% | ||
| Q1 25 | 1.2% | 7.0% | ||
| Q4 24 | 7.7% | 7.8% | ||
| Q3 24 | 6.2% | 6.6% | ||
| Q2 24 | 6.5% | -31.3% | ||
| Q1 24 | 4.4% | 3.2% |
| Q4 25 | 0.3% | 6.8% | ||
| Q3 25 | 1.0% | 14.5% | ||
| Q2 25 | 1.1% | 8.4% | ||
| Q1 25 | 0.8% | 4.5% | ||
| Q4 24 | 5.6% | 6.1% | ||
| Q3 24 | 4.4% | 3.8% | ||
| Q2 24 | 4.7% | -30.3% | ||
| Q1 24 | 8.0% | 0.8% |
| Q4 25 | $0.07 | $0.40 | ||
| Q3 25 | $0.20 | $0.84 | ||
| Q2 25 | $0.21 | $0.46 | ||
| Q1 25 | $0.17 | $0.24 | ||
| Q4 24 | $1.19 | $0.37 | ||
| Q3 24 | $0.85 | $0.23 | ||
| Q2 24 | $0.88 | $-1.84 | ||
| Q1 24 | $1.56 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $616.8M | $865.9M |
| Total Assets | $2.1B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.0M | $375.2M | ||
| Q3 25 | $191.5M | $340.1M | ||
| Q2 25 | $33.1M | $224.7M | ||
| Q1 25 | $29.6M | $99.0M | ||
| Q4 24 | $33.7M | $229.9M | ||
| Q3 24 | $51.8M | $103.8M | ||
| Q2 24 | $30.7M | $19.4M | ||
| Q1 24 | $21.4M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $616.8M | $865.9M | ||
| Q3 25 | $613.3M | $890.7M | ||
| Q2 25 | $605.2M | $833.8M | ||
| Q1 25 | $599.0M | $789.2M | ||
| Q4 24 | $598.3M | $764.9M | ||
| Q3 24 | $606.1M | $732.5M | ||
| Q2 24 | $570.3M | $706.5M | ||
| Q1 24 | $560.6M | $856.2M |
| Q4 25 | $2.1B | $2.2B | ||
| Q3 25 | $2.2B | $2.2B | ||
| Q2 25 | $1.9B | $2.1B | ||
| Q1 25 | $1.9B | $2.0B | ||
| Q4 24 | $2.0B | $2.2B | ||
| Q3 24 | $2.0B | $2.1B | ||
| Q2 24 | $1.9B | $2.0B | ||
| Q1 24 | $1.8B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2M | $114.1M |
| Free Cash FlowOCF − Capex | $-12.4M | — |
| FCF MarginFCF / Revenue | -1.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | -0.50× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $14.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.2M | $114.1M | ||
| Q3 25 | $47.3M | $137.3M | ||
| Q2 25 | $-5.7M | $137.2M | ||
| Q1 25 | $28.7M | $-117.5M | ||
| Q4 24 | $-39.8M | $133.0M | ||
| Q3 24 | $79.6M | $91.8M | ||
| Q2 24 | $36.1M | $107.0M | ||
| Q1 24 | $43.0M | $-125.2M |
| Q4 25 | $-12.4M | — | ||
| Q3 25 | $35.0M | — | ||
| Q2 25 | $-26.2M | — | ||
| Q1 25 | $18.0M | — | ||
| Q4 24 | $-57.4M | — | ||
| Q3 24 | $68.5M | — | ||
| Q2 24 | $26.3M | — | ||
| Q1 24 | $32.4M | — |
| Q4 25 | -1.6% | — | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | -4.3% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | -7.7% | — | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 4.0% | — | ||
| Q1 24 | 4.6% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.5% | — |
| Q4 25 | -0.50× | 3.39× | ||
| Q3 25 | 7.05× | 1.91× | ||
| Q2 25 | -0.81× | 3.49× | ||
| Q1 25 | 5.82× | -5.66× | ||
| Q4 24 | -0.96× | 4.36× | ||
| Q3 24 | 2.66× | 4.72× | ||
| Q2 24 | 1.17× | — | ||
| Q1 24 | 0.77× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAL
| Brand Portfolio | $383.7M | 49% |
| Landed Wholesale | $148.1M | 19% |
| Wholesale E Commerce | $75.0M | 9% |
| Ecommerce | $68.8M | 9% |
| Stuart Weitzman Brand | $45.8M | 6% |
| Landed Wholesale Ecommerce Drop Ship | $30.6M | 4% |
| First Cost Wholesale | $14.9M | 2% |
| Clt Brand Solutions | $10.2M | 1% |
| License And Royalty | $2.1M | 0% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
